During the last three years also deep sequencing data on solid cancer unveiled unexpected germline gene aberrations in neuroendocrine neoplasia (e.g., MUTYH, CHEK2, and BRCA2 genes in pancreas NEN) [28, 29] together with a substantial absence of known cancer drivers [30, 31]. This evidence concerns the gene CHEK2 and cancer.